Pharmaceutical companies are under growing pressure to demonstrate outcomes beyond clinical trials. VSI Technologies enables life sciences firms to unlock the power of real-world data (RWD) and real-world evidence (RWE) to improve access, safety, and value.
Challenges with RWD/RWE Adoption
- Inconsistent data quality and regulatory complexity
- Integration gaps between clinical, claims, EMR, and digital sources
- Limited analytics readiness and content reuse
VSI's Pharma Data Enablement Services1. RWD Harmonization and Ontology Mapping2. Integrated Content Platforms for Scientific and Regulatory Submissions3. AI-Based Signal Detection and Patient Stratification Models4. Data Governance, Traceability, and Compliance Frameworks
Outcomes
- 30% acceleration in regulatory submission timelines
- Better post-market safety monitoring
- More effective launch planning and patient outreach
Conclusion
RWE isn't just a compliance requirement–it's a competitive advantage. VSI makes it actionable.
